TheraRadar
← Back
Data updated: Mar 29, 2026

HISUN PHARM HANGZHOU

CardiovascularOncologyInfectious Disease
Generics

HISUN PHARM HANGZHOU is a generic drug manufacturer focused on Cardiovascular, Oncology, Infectious Disease.

2009
Since
18
Drugs
-
Trials
283
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

MICAFUNGIN SODIUM 2026-02-24
OLANZAPINE 2026-02-09
Labeling
OLANZAPINE 2026-02-09
Labeling
PRAVASTATIN SODIUM 2026-02-06
Labeling
TICAGRELOR 2026-02-06
DOXORUBICIN HYDROCHLORIDE 2026-02-03
EPIRUBICIN HYDROCHLORIDE 2026-01-30
Labeling
DAPTOMYCIN 2026-01-30
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 30%
3 drugs
Oncology 30%
3 drugs
Infectious Disease 20%
2 drugs
Neurology 10%
1 drugs
Dermatology 10%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular